OTC - ACTIVE INGREDIENT SECTION
Miconazole 2%
Miconazole 2%
Antifungal
Skin Antifungal
Extremely flammable:
Contents under pressure. Keep away from fire, sparks, and heated surfaces. Do not puncture or incinerate container. Exposure to temperatures above 120°F may cause bursting. Intentional misuse by deliberately concentrating and inhaling the contents can be harmful or fatal.
When using this product
avoid contact with the eyes or mouth
use only as directed
Stop use and ask a doctor if
irritation occurs
no improvement within 4 weeks for athlete's foot and ringworm, and 2 weeks for jock itch
- For intravaginal use only.
- Do not use during menstruation.
- Use entire course of treatment even if symptoms improve earlier.
wash affected area and dry thoroughly
shake bottle well and spray a thin layer over affected area twice daily (morning and night) or as directed by a doctor
If swallowed, get medical help or contact a Poison Control Center right away.
PROPANEDIOL,ETHYLHEXYLGLYCERIN,PHENOXYETHANOL,CAFFEINE,AQUA,GLYCERYL GLUCOSIDE,GLYCERIN
ALPHA-GLUCAN OLIGOSACCHARIDE
,DIPEPTIDE DIAMINOBUTYROYL BENZYLAMIDE DIACETATE
ACETYL HEXAPEPTIDE-8
Secret Oil
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 84556-185 | 84556-185-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PROPANEDIOL | 5965N8W85T | IACT |
| MICONAZOLE | 7NNO0D7S5M | ACTIB |
| ETHYLHEXYLGLYCERIN | 147D247K3P | IACT |
| PHENOXYETHANOL | HIE492ZZ3T | IACT |
| CAFFEINE | 3G6A5W338E | IACT |
| AQUA | 059QF0KO0R | IACT |
| GLYCERYL GLUCOSIDE | 3297VXM8Z6 | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| ALPHA-GLUCAN OLIGOSACCHARIDE | S95658MI3W | IACT |
| DIPEPTIDE DIAMINOBUTYROYL BENZYLAMIDE DIACETATE | 38H206R00R | IACT |
| ACETYL HEXAPEPTIDE-8 | L4EL31FWIL | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 3fd2865e-4ef7-b153-e063-6394a90af854 | 397d2ba7-7fea-40e1-e063-6394a90a2dce | 2025-09-27 | Warnings, Adverse reactions | 397d2ba7-7fea-40e1-e063-6394a90a2dce |
Adverse event summaries are temporarily unavailable. Other product information remains available.